etrolizumab
roche
['bergamot', 'crohn', 'ibd']
up next, clinical trials in #crohnsdisease. severine vermeire kicks things off with results of bergamot, a phase 3 trial of etrolizumab for patients with moderately-to-severely active crohn's disease #uegweek #gitwitter #ibd 
The Lancet Gastroenterology & Hepatology publishes high-quality peer-reviewed research and reviews, comment, and news #gastroenterology #hepatology. IF=45.042